The METABANK score: A clinical tool to predict survival after stereotactic radiotherapy for oligometastatic disease.

CONCLUSION: We propose a prognostic score applicable in a variety of primary tumors and disease locations, including presence of brain metastases. The nomogram and risk groups can be used to stratify patients in new trials and to support individualized care for oligometastatic patients. An online calculator will become available at predictcancer.org.
PMID: 30935566 [PubMed - in process]

Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - March 31, 2019 Category: Radiology Authors: Van den Begin R, Engels B, Collen C, de Vin T, Defauw A, Dubaere E, Barbé K, De Ridder M Tags: Radiother Oncol Source Type: research